141 related articles for article (PubMed ID: 35385855)
1. An Atypical Deep Penetrating Nevus With Mutations in Beta Catenin , BRAFV600E , and IDH1R132C in an 8-Year-Old Boy.
Ireland AM; Wood BA; Whitfield J; Amanuel B; Harvey NT; Mesbah Ardakani N
Am J Dermatopathol; 2022 Aug; 44(8):607-610. PubMed ID: 35385855
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
[TBL] [Abstract][Full Text] [Related]
3. Combined deep penetrating nevi of the conjunctiva are relatively common lesions characterised by BRAFV600E mutation and activation of the beta catenin pathway: a clinicopathological analysis of 34 lesions.
Šekoranja D; Vergot K; Hawlina G; Pižem J
Br J Ophthalmol; 2020 Jul; 104(7):1016-1021. PubMed ID: 31558492
[TBL] [Abstract][Full Text] [Related]
4. Combination of Congenital and Deep Penetrating Nevus by Acquisition of β-Catenin Activation.
Garrido MC; Nájera L; Navarro A; Huerta V; Garrido E; Rodriguez-Peralto JL; Requena L
Am J Dermatopathol; 2020 Dec; 42(12):948-952. PubMed ID: 32568834
[TBL] [Abstract][Full Text] [Related]
5. NGS-Based Analysis of Atypical Deep Penetrating Nevi.
Manca A; Sini MC; Cesinaro AM; Portelli F; Urso C; Lentini M; Cardia R; Alos L; Cook M; Simi S; Paliogiannis P; De Giorgi V; Cossu A; Palmieri G; Massi D
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205480
[TBL] [Abstract][Full Text] [Related]
6. Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing.
Ebbelaar CF; Schrader AMR; van Dijk M; Meijers RWJ; de Leng WWJ; Bloem LT; Jansen AML; Blokx WAM;
Mod Pathol; 2022 Aug; 35(8):1110-1120. PubMed ID: 35184152
[TBL] [Abstract][Full Text] [Related]
7. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of atypical deep penetrating nevus progressing to melanoma.
Isales MC; Khan AU; Zhang B; Compres EV; Kim D; Tan TL; Beaubier N; Gerami P
J Cutan Pathol; 2020 Dec; 47(12):1150-1154. PubMed ID: 32526042
[TBL] [Abstract][Full Text] [Related]
9. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma.
Robson A; Morley-Quante M; Hempel H; McKee PH; Calonje E
Histopathology; 2003 Dec; 43(6):529-37. PubMed ID: 14636253
[TBL] [Abstract][Full Text] [Related]
10. Conventional and Atypical Deep Penetrating Nevus, Deep Penetrating Nevus-like Melanoma, and Related Variants.
Gill P; Aung PP
Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336833
[TBL] [Abstract][Full Text] [Related]
11. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls.
Vanderbeck K; Rothrock AT; Cho WC; Nagarajan P; Aung PP; Hudgens C; Bassett RL; Ivan D; Prieto VG; Curry JL; Torres-Cabala CA
Am J Dermatopathol; 2023 Aug; 45(8):549-556. PubMed ID: 37462205
[TBL] [Abstract][Full Text] [Related]
12. The deep penetrating nevus.
Strazzula L; Senna MM; Yasuda M; Belazarian L
J Am Acad Dermatol; 2014 Dec; 71(6):1234-40. PubMed ID: 25175710
[TBL] [Abstract][Full Text] [Related]
13. Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus?
High WA; Alanen KW; Golitz LE
J Am Acad Dermatol; 2006 Sep; 55(3):460-6. PubMed ID: 16908352
[TBL] [Abstract][Full Text] [Related]
14. Deep penetrating nevus.
Mehregan DA; Mehregan AH
Arch Dermatol; 1993 Mar; 129(3):328-31. PubMed ID: 8447669
[TBL] [Abstract][Full Text] [Related]
15. Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization.
Castillo P; Castrejon N; Marginet M; Massi D; Alamon F; Teixido C; Montironi C; Garcia-Herrera A; Albero-Gonzalez R; Matas J; Puig S; Alos L
Clin Exp Dermatol; 2024 Mar; 49(4):356-363. PubMed ID: 37995304
[TBL] [Abstract][Full Text] [Related]
16. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
17. Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi.
Yeh I; Lang UE; Durieux E; Tee MK; Jorapur A; Shain AH; Haddad V; Pissaloux D; Chen X; Cerroni L; Judson RL; LeBoit PE; McCalmont TH; Bastian BC; de la Fouchardière A
Nat Commun; 2017 Sep; 8(1):644. PubMed ID: 28935960
[TBL] [Abstract][Full Text] [Related]
18. ALK Rearrangements Are Infrequent in Cellular Blue Nevus and Deep Penetrating Nevus.
Dunn ALJ; Gardner JM; Kaley JR; Bellamy W; Shalin SC
Am J Dermatopathol; 2018 Jul; 40(7):469-478. PubMed ID: 29923908
[TBL] [Abstract][Full Text] [Related]
19. CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases.
Teunissen BT; Knuiman GJ; Eijkelenboom A; Wauters CAP; Wouda S; Blokx WAM
Virchows Arch; 2018 Apr; 472(4):683-687. PubMed ID: 29086002
[No Abstract] [Full Text] [Related]
20. Linear arrangement of multiple deep penetrating nevi: report of first case and review of literature.
Hassan AS; Schulte KW; Ruzicka T; Megahed M
Arch Dermatol; 2003 Dec; 139(12):1608-10. PubMed ID: 14676079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
